Septic shock due to infections with gram-negative bacteria remains a m
ajor clinical problem for infectious disease specialists, although our
understanding of the pathophysiology of this syndrome has improved gr
eatly over the past 5 years. The discovery of lipopolysaccharide (LPS)
binding protein, a serum protein that catalyses the transfer of LPS t
o cellular receptors for LPS, was a major breakthrough. The finding th
at CD14, a glycophosphatidylinositol-linked membrane protein expressed
by macrophages, is a receptor for LPS has made a major difference in
our understanding of cellular activation by LPS. We will review studie
s dealing with LPS's binding to these proteins and its activation of c
ells. A better understanding of septic shock at the molecular level sh
ould lead to the development of new treatments for this lethal disease
.